VRDN 8-K 2026-08-06

Viridian Therapeutics, Inc.\DE (VRDN) 8-K dated 2026-08-06 — accession 0001193125-26-336691. This URL is the filing, not the VRDN hub.

Viridian Therapeutics, Inc.\DE (VRDN) is a biotechnology company listed on US.

Viridian Therapeutics, Inc.\DE filed a 8-K on 2026-08-06. Accession 0001193125-26-336691.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported VRDN revenue for 2025-12-31 was $70.8M. Net income was -$342.6M. Revenue was up 23359.9% from 2024-12-31 to 2025-12-31. VRDN currently screens at market cap $1.39B.

Not investment advice. The VRDN SEC hub lists recent forms. The stock page is the research view.